• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 4/25/24: Meta’s AI Assistant Can’t Be Trusted, Remote Patient Monitoring Analysis Report 2024 & more


The latest news for pharma industry insiders.

Paving the Way for AI’s Potential in Clinical Trials

Rust Felix, CEO and Co-founder of Slope, addresses a variety of topics around artificial intelligence including challenges, streamlining data management, and human intervention.

Accurate, Complete Data Entry Is Key to Medication Safety

Carefully checking every piece of information and proofreading for accuracy is crucial to ensure patient safety.

Meta’s A.I. Assistant Is Fun to Use, but It Can’t Be Trusted

Despite Mark Zuckerberg’s hope for the chatbot to be the smartest, it struggles with facts, numbers and web search.

Remote Patient Monitoring Analysis Report 2024

The global remote patient monitoring market is projected to reach $116.84 billion by 2031, at a CAGR of 13.7% from 2024 to 2031.

Authenticx on LinkedIn:

“By embracing a data-driven approach and leveraging conversational AI insights, healthcare organizations can confidently navigate fads to provide education and exceptional care delivery while maintaining operational efficiency.”

Authenticx Founder & CEO Amy Brown shares insights for #pharma organizations and leaders. 💡 By leveraging conversation data to analyze and identify trends, they can inform their patient journey more efficiently and effectively while minimizing misinformation.

📖 Read her article to more proactively communicate and lead with healthcare trends: https://lnkd.in/gNNNh2Yq
#AIinHealthcare #HealthcareLeaders #HealthTech #ListenAtScale

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs